Skip to content

New AbbVie hepatitis C combination cures 99% of people with cirrhosis

Xavier Forns at the International Liver Congress 2017. Photo by Liz Highleyman, hivandhepatitis.com

Direct-acting antivirals for hepatitis C not linked to higher liver cancer risk in most studies

Gregory Dore at the International Liver Congress 2017. Photo by Liz Highleyman, hivandhepatitis.com

European HCV treatment access survey shows big variations in eligibility

Curing hepatitis C reduces cardiovascular risk

Monitoring of progress towards 90-90-90 blighted by poor quality reporting

Hepatitis C treatment can be provided successfully at syringe programme sites

Study shows that HIV-positive nursing mothers in London can struggle to obtain and afford formula milk

Black HIV-positive MSM in US still have lower rates of ART use

Homeless US military veterans have high rates of HIV, HCV and HBV